As of 2024-12-14, the Relative Valuation of Arecor Therapeutics PLC (AREC.L) is - GBP. This relative valuation is based on P/E multiples. With the latest stock price at 76.50 GBP, the upside of Arecor Therapeutics PLC based on Relative Valuation is -.
The range of the Relative Valuation is - GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-09 | -3.33 |
| 2024-12-06 | -3.33 |
| 2024-12-05 | -3.33 |
| 2024-12-04 | -3.33 |
| 2024-12-03 | -3.33 |
| 2024-12-02 | -3.33 |
| 2024-11-29 | -3.33 |
| 2024-11-28 | -3.33 |
| 2024-11-27 | -3.33 |
| 2024-11-26 | -3.33 |
| 2024-11-25 | -3.33 |
| 2024-11-22 | -3.27 |
| 2024-11-21 | -3.33 |
| 2024-11-20 | -3.33 |
| 2024-11-19 | -3.33 |
| 2024-11-18 | -3.33 |
| 2024-11-15 | -3.31 |
| 2024-11-14 | -3.31 |
| 2024-11-13 | -3.31 |
| 2024-11-12 | -3.31 |
| 2024-11-11 | -3.31 |
| 2024-11-08 | -3.27 |
| 2024-11-07 | -3.27 |
| 2024-11-06 | -3.27 |
| 2024-11-05 | -3.31 |
| 2024-11-04 | -3.27 |
| 2024-11-01 | -3.27 |
| 2024-10-31 | -3.27 |
| 2024-10-30 | -3.27 |
| 2024-10-29 | -3.27 |
| 2024-10-28 | -3.35 |
| 2024-10-25 | -3.35 |
| 2024-10-24 | -3.25 |
| 2024-10-23 | -3.22 |
| 2024-10-22 | -3.22 |
| 2024-10-21 | -3.22 |
| 2024-10-18 | -3.22 |
| 2024-10-17 | -3.22 |
| 2024-10-16 | -3.22 |
| 2024-10-15 | -3.05 |
| 2024-10-14 | -3.01 |
| 2024-10-11 | -3.01 |
| 2024-10-10 | -3.01 |
| 2024-10-09 | -3.01 |
| 2024-10-08 | -2.94 |
| 2024-10-07 | -2.94 |
| 2024-10-04 | -2.94 |
| 2024-10-03 | -2.88 |
| 2024-10-02 | -2.88 |
| 2024-10-01 | -2.88 |